Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

695 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Kawasaki E, et al. Among authors: hanafusa t. J Diabetes Investig. 2023 Apr;14(4):570-581. doi: 10.1111/jdi.13980. Epub 2023 Jan 23. J Diabetes Investig. 2023. PMID: 36691729 Free PMC article.
Fulminant Type 1 Diabetes-East and West.
Imagawa A, Hanafusa T. Imagawa A, et al. Among authors: hanafusa t. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1473-e1478. doi: 10.1210/clinem/dgad329. J Clin Endocrinol Metab. 2023. PMID: 37309685
The current status and novel advances of boron neutron capture therapy clinical trials.
Zhou T, Igawa K, Kasai T, Sadahira T, Wang W, Watanabe T, Bekku K, Katayama S, Iwata T, Hanafusa T, Xu A, Araki M, Michiue H, Huang P. Zhou T, et al. Among authors: hanafusa t. Am J Cancer Res. 2024 Feb 15;14(2):429-447. doi: 10.62347/HBBE6868. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455422 Free PMC article. Review.
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H; Japanese Type 1 Diabetes Database Study (TIDE-J). Kawasaki E, et al. Among authors: hanafusa t. J Diabetes Investig. 2024 Mar 7. doi: 10.1111/jdi.14178. Online ahead of print. J Diabetes Investig. 2024. PMID: 38451108 Free article.
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Kawasaki E, et al. Among authors: hanafusa t. J Diabetes Investig. 2023 Jan;14(1):58-66. doi: 10.1111/jdi.13910. Epub 2022 Sep 30. J Diabetes Investig. 2023. PMID: 36177861 Free PMC article.
Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design.
Chujo D, Imagawa A, Yasuda K, Abiru N, Awata T, Fukui T, Ikegami H, Kawasaki E, Katsuki T, Kobayashi T, Kozawa J, Nagasawa K, Ohtsu H, Oikawa Y, Osawa H, Shimada A, Shimoda M, Takahashi K, Tsuchiya K, Tsujimoto T, Yasuda H, Hanafusa T, Kajio H. Chujo D, et al. Among authors: hanafusa t. Diabetol Int. 2021 Sep 6;13(1):288-294. doi: 10.1007/s13340-021-00541-2. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059265 Free PMC article.
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.
Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, Kanda H, Kitahara H, Kinoshita M, Nakasu I, Hattori N, Horiuchi Y, Maruyama R, Mizutani H, Murakami Y, Watanabe C, Kume A, Hanafusa T, Hamaguchi M, Yoshioka A, Egami Y, Matsuo K, Matsuda T, Akamatsu M, Yorozuya T, Takayama S, Yokozeki H. Fujimoto T, et al. Among authors: hanafusa t. J Dermatol. 2021 Aug;48(8):1149-1161. doi: 10.1111/1346-8138.15927. Epub 2021 May 26. J Dermatol. 2021. PMID: 34041788 Free PMC article. Clinical Trial.
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI; TRUST2 study group. Katsuno T, et al. Among authors: hanafusa t. Adv Ther. 2021 Mar;38(3):1514-1535. doi: 10.1007/s12325-021-01631-y. Epub 2021 Jan 28. Adv Ther. 2021. PMID: 33507500 Clinical Trial.
695 results